COMMUNIQUÉS West-GlobeNewswire

Marrone Bio Innovations, Inc. to Present at 10th Annual LD Micro Main Event Investor Conference in Los Angeles

21/11/2017 - 14:30

DAVIS, Calif., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (the “Company” or “MBI”) (NASDAQ: MBII ), a leading provider of bio-based pest management and plant health products for the agriculture, [...]

Dova Pharmaceuticals to Present at Evercore ISI Conference

21/11/2017 - 14:30

DURHAM, N.C., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ) today announced that Alex Sapir, President and Chief Executive Officer, will present a company overview at the Evercore ISI [...]

Golden Leaf Holdings to Hold Conference Call to Review Third Quarter 2017 Results

21/11/2017 - 14:30

TORONTO, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. ("GLH" or the "Company") (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company built around recognized brands, today announced that it [...]

Novelion Therapeutics Provides Update on Agreement between Aegerion Pharmaceuticals and U.S. Department of Justice

21/11/2017 - 14:30

VANCOUVER, British Columbia, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN ), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare [...]

Teligent, Inc. Announces FDA Approval of Erythromycin Topical Solution USP, 2%

21/11/2017 - 14:30

BUENA, N.J., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]

AIT Therapeutics to Hold Clinical Update Meeting on November 28, 2017 at 7:30 a.m.

21/11/2017 - 14:30

Will present data from its NO-NTM Phase 2 clinical trial for patients suffering from Nontuberculous Mycobacteria (NTM) Abscessus NEW YORK, Nov. 21, 2017 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical- [...]

Catalyst Pharmaceuticals Announces Phase 2 Study of Firdapse® in Ambulatory Patients with Spinal Muscular Atrophy (SMA)

21/11/2017 - 14:03

CORAL GABLES, Fla., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX ), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare [...]

Auris Medical News Release

21/11/2017 - 14:01

Auris Medical to Report Third Quarter 2017 Financial Results and Provide Business Update on Tuesday, November 28, 2017 Zug, Switzerland, November 21, 2017 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage [...]

CrownBio’s Translatable FATZO Model Utilized in Eli Lilly’s Preclinical Type 2 Diabetes Research Programs

21/11/2017 - 14:00

SANTA CLARA, Calif., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company [...]

Altimmune to Present at the 29th Annual Piper Jaffray Conference

21/11/2017 - 14:00

GAITHERSBURG, Md., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT ), a clinical-stage immunotherapeutics company, today announced that Bill Enright, president and chief executive officer of Altimmune, [...]

Genocea to Present at 29th Annual Piper Jaffray Healthcare Conference

21/11/2017 - 14:00

CAMBRIDGE, Mass., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA ), a biopharmaceutical company developing neoantigen cancer vaccines, today announced that Chip Clark, president and chief [...]

Menlo Therapeutics Begins Phase 2 Clinical Trial for Pruritus Associated with Psoriasis

21/11/2017 - 14:00

REDWOOD CITY, Calif., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc., a late-stage biopharmaceutical company developing a neurokinin 1 (NK‐1) receptor antagonist (serlopitant) for the treatment of pruritus ( [...]

Invuity to Present at Piper Jaffray Healthcare Conference

21/11/2017 - 14:00

SAN FRANCISCO, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY ), a leading medical technology company focused on minimal access surgery, today announced that company management is scheduled to present at [...]

TESARO Secures $500 Million Non-Dilutive Term Loan Financing

21/11/2017 - 14:00

WALTHAM, Mass., Nov. 21, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO ), an oncology focused biopharmaceutical company, announced today that it has entered into a definitive term loan agreement with BIOPHARMA [...]

aTyr Pharma to Participate at the Piper Jaffray 29th Annual Healthcare Conference

21/11/2017 - 14:00

SAN DIEGO, Nov. 21, 2017 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company engaged in the discovery and development of immuno-modulatory protein therapeutics to treat patients suffering [...]

Ovid Therapeutics Announces Five Poster Presentations on TAK-935/OV935 at the American Epilepsy Society 71st Annual Meeting

21/11/2017 - 14:00

NEW YORK, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID ), a biopharmaceutical company committed to developing medicines for patients with rare neurological diseases, today announced that it [...]

New Data from Zogenix’s Phase 3 Trial of ZX008 in Dravet Syndrome (Study 1) and Findings on Disease Impact to be Presented at 71st American Epilepsy Society Annual Meeting

21/11/2017 - 14:00

Updated Results of Phase 2 Study of ZX008 in Lennox Gastaut Syndrome to be Presented Data Demonstrating Disease Burden and Negative Impact on Quality of Life of Patients and Families Will Also be Presented EMERYVILLE, [...]

VBL Therapeutics to Present at the Piper Jaffray 29th Annual Healthcare Conference

21/11/2017 - 14:00

TEL AVIV, Israel, Nov. 21, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]

Aclaris Therapeutics Presents New Data at American College of Rheumatology Annual Meeting For ATI-450, a MK2 pathway Inhibitor

21/11/2017 - 14:00

MALVERN, Pa., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (Nasdaq: ACRS ), a dermatologist-led, biopharmaceutical company focused on identifying, developing and commercializing innovative and [...]